Ralitza Gueorguieva, PhD
Senior Research Scientist in Biostatistics; Director of Biostatistics in PsychiatryCards
About
Titles
Senior Research Scientist in Biostatistics; Director of Biostatistics in Psychiatry
Biography
Dr. Gueorguieva obtained her Ph.D. in Statistics from University of Florida in 1999 and has been a faculty member of the Department of Biostatistics at Yale University School of Public Health since 2000. Her research interests are in methodological development of models for longitudinal data and outcomes of different types, assessment of risk and the application of innovative statistical approaches for clinical trials data. She has developed statistical techniques for simultaneous analysis of repeatedly measured categorical and continuous outcomes, risk assessment screening algorithms, models for joint analysis of longitudinal and survival outcomes, and has applied trajectory-based approaches and recursive partitioning methods to the assessment of treatment effects. Dr. Gueorguieva is collaborating extensively with psychiatric researchers on clinical trials and observational studies in tobacco research, alcoholism, substance abuse, depression and anxiety disorders, eating disorders, women's behavioral health, schizophrenia, bipolar disorder, obsessive-compulsive disorder and posttraumatic stress disorder. She advocates the use of modern statistical methods such as mixed and mixture models, tree-based methods and nonparametric alternatives to address the complexity of psychiatric data.
Appointments
Biostatistics
Senior Research ScientistPrimary
Other Departments & Organizations
- ADVANCE Study
- Biostatistics
- Biostatistics
- Center for Biomedical Data Science
- Center for the Translational Neuroscience of Alcohol
- Neuroscience Research Training Program (NRTP)
- Statistical Methods in Psychiatry and Related Fields: Longitudinal, Clustered and Other Repeated Measures Data
- Yale School of Public Health
- Yale School of Public Health - NEW
- Yale Tobacco Center of Regulatory Science
Education & Training
- PhD
- University of Florida, Statistics (1999)
- MSc
- University of Florida, Statistics (1996)
- MSc
- Sofia University, Informatics (1994)
Research
Overview
Dr. Gueorguieva's research interests are in methodological development of models for longitudinal data and outcomes of different types, assessment of risk and the application of innovative statistical approaches for the analyses of clinical trials data. She has developed statistical techniques for simultaneous analysis of repeatedly measured categorical and continuous outcomes, and of longitudinal and survival outcomes, has developed risk assessment screening algorithms, and has applied trajectory-based approaches and recursive partitioning methods to the assessment of treatment effects. Dr. Gueorguieva is collaborating extensively with psychiatric researchers on clinical trials and observational studies in tobacco research, alcoholism, substance abuse, depression and anxiety disorders, women's behavioral health, schizophrenia, bipolar disorder, obsessive-compulsive disorder and posttraumatic stress disorder. She advocates the use of modern statistical methods such as mixed and mixture models, tree-based methods and nonparametric alternatives to address the complexity of psychiatric data.
- Predictors and Moderators of Response to Treatment
- Growth Mixture Modeling of Longitudinal Data
- Joint Analysis of Repeatedly Measured Outcomes and Competing Risks
- Mixture Models for Semi-Ordinal Data
- Mixture Models for Simultaneous Analysis of Abstinence, Frequency and Intensity of Drinking
- Center for the Translational Neuroscience of Alcoholism
- Yale Center for the Study of Tobacco Product Use and Addiction: Flavors, Nicotine and Other Constituents
- YALE-SCORE on Sex Differences in Alcohol Use Disorder
- The STRONG STAR Consortium to Alleviate PTSD
Medical Research Interests
Public Health Interests
Academic Achievements & Community Involvement
News & Links
News
- December 11, 2024Source: The American Journal of Psychiatry
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial
- October 24, 2024Source: Cambridge University Press
Lisdexamfetamine Maintenance Treatment for Binge-Eating Disorder Following Successful Treatments
- May 01, 2024Source: Yale News
Understanding Youth Nicotine Use to Prevent Initiation and Escalation
- January 12, 2024Source: Yale News
Quest for Personalized Medicine Hits a Snag